“Combination therapies against cancer: new opportunities for translational research ”
The expected impact of the call is to improve the efficacy of personalized treatment of cancer patients through the development of new combinatorial treatment strategies, based on a better understanding of drug mechanistic functions and of their impact on the disease course. The specific objectives of this funding opportunity are to stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.
For further information, please visit our dedicated JTC 2024 Webpage.
Timeline of the Call
27 March 2024 | Publication of the call pre-announcement |
26 April 2024 | Publication of the call |
26 April 2024 at 16:00 (CEST) | Opening of the on-line submission system for pre-proposals |
05 July 2024 at 12:00 (CEST) | Deadline for pre-proposal submission |
18 October 2024 | Communication of the results of the pre-proposal assessment and invitation for full-proposal stage |
18 November 2024 | Opening of the submission system for full proposals |
29 November 2024 at 12:00 (CET) | Deadline for full-proposal submission |
Expected for May 2025 | Communication of the funding decisions to the applicants |
September 2025 | Expected project start (also subject to regional/national procedures) |